281 related articles for article (PubMed ID: 27933717)
1. Mass Cytometry Analytical Approaches Reveal Cytokine-Induced Changes in Natural Killer Cells.
Vendrame E; Fukuyama J; Strauss-Albee DM; Holmes S; Blish CA
Cytometry B Clin Cytom; 2017 Jan; 92(1):57-67. PubMed ID: 27933717
[TBL] [Abstract][Full Text] [Related]
2. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.
Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J
BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364
[TBL] [Abstract][Full Text] [Related]
3. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
4. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.
Marras F; Nicco E; Bozzano F; Di Biagio A; Dentone C; Pontali E; Boni S; Setti M; Orofino G; Mantia E; Bartolacci V; Bisio F; Riva A; Biassoni R; Moretta L; De Maria A
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11970-5. PubMed ID: 23818644
[TBL] [Abstract][Full Text] [Related]
6. Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells.
Marafini I; Monteleone I; Di Fusco D; Sedda S; Cupi ML; Fina D; Paoluzi AO; Pallone F; Monteleone G
PLoS One; 2016; 11(5):e0155103. PubMed ID: 27171408
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.
Cifaldi L; Prencipe G; Caiello I; Bracaglia C; Locatelli F; De Benedetti F; Strippoli R
Arthritis Rheumatol; 2015 Nov; 67(11):3037-46. PubMed ID: 26251193
[TBL] [Abstract][Full Text] [Related]
9. Bronchiolitis obliterans syndrome is associated with increased peripheral blood natural killer and natural killer T-like granzymes, perforin, and T-helper-type 1 pro-inflammatory cytokines.
Hodge G; Hodge S; Holmes-Liew CL; Reynolds PN; Holmes M
J Heart Lung Transplant; 2012 Aug; 31(8):888-95. PubMed ID: 22759800
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function.
Carreira-Santos S; López-Sejas N; González-Sánchez M; Sánchez-Hernández E; Pera A; Hassouneh F; Durán E; Solana R; Casado JG; Tarazona R
Front Immunol; 2023; 14():1256404. PubMed ID: 37908353
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15.
Vuletić AM; Jovanić IP; Jurišić VB; Milovanović ZM; Nikolić SS; Tanić NT; Konjević GM
Melanoma Res; 2015 Feb; 25(1):22-34. PubMed ID: 25380182
[TBL] [Abstract][Full Text] [Related]
12. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
[TBL] [Abstract][Full Text] [Related]
13. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions.
Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q
Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431
[TBL] [Abstract][Full Text] [Related]
14. IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells.
Choi YH; Lim EJ; Kim SW; Moon YW; Park KS; An HJ
J Immunother Cancer; 2019 Jul; 7(1):168. PubMed ID: 31277710
[TBL] [Abstract][Full Text] [Related]
15. The effects of IL-17 upon human natural killer cells.
Al Omar S; Flanagan BF; Almehmadi M; Christmas SE
Cytokine; 2013 Apr; 62(1):123-30. PubMed ID: 23490420
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections.
Dalle JH; Menezes J; Wagner E; Blagdon M; Champagne J; Champagne MA; Duval M
Pediatr Res; 2005 May; 57(5 Pt 1):649-55. PubMed ID: 15718362
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells.
Pintaric M; Gerner W; Saalmüller A
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
Ranganath T; Simpson LJ; Ferreira AM; Seiler C; Vendrame E; Zhao N; Fontenot JD; Holmes S; Blish CA
Front Immunol; 2020; 11():714. PubMed ID: 32391016
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.
Verstrepen BE; Nieuwenhuis IG; Mooij P; Bogers WM; Boonstra A; Koopman G
Clin Exp Immunol; 2016 Jul; 185(1):42-9. PubMed ID: 26850369
[TBL] [Abstract][Full Text] [Related]
20. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]